158 related articles for article (PubMed ID: 34889164)
1. Long non-coding RNA CASC7 suppresses malignant behaviors of breast cancer by regulating miR-21-5p/FASLG axis.
Wang G; Duan P; Liu F; Wei Z
Bioengineered; 2021 Dec; 12(2):11555-11566. PubMed ID: 34889164
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA CASC7 inhibits the proliferation and migration of papillary thyroid cancer cells by inhibiting miR-34a-5p.
Sun W; Yin D
J Physiol Sci; 2021 Mar; 71(1):9. PubMed ID: 33706708
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA anti-differentiation non-coding RNA affects proliferation, invasion, and migration of breast cancer cells by targeting miR-331.
Jiang C; Shi X; Yi D; Wang R; Xu F; Guan W; Sang J
Bioengineered; 2021 Dec; 12(2):12236-12245. PubMed ID: 34783641
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA (lncRNA) HOXD-AS2 promotes glioblastoma cell proliferation, migration and invasion by regulating the miR-3681-5p/MALT1 signaling pathway.
Zhong X; Cai Y
Bioengineered; 2021 Dec; 12(2):9113-9127. PubMed ID: 34802389
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of long noncoding RNA cancer susceptibility candidate 7 attenuates hepatocellular carcinoma development by targeting microRNA-30a-5p.
Li D; Lu L; Liu M; Sun J
Bioengineered; 2022 Apr; 13(4):11296-11308. PubMed ID: 35484972
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA NORAD inhibition upregulates microRNA-323a-3p to suppress tumorigenesis and development of breast cancer through the PUM1/eIF2 axis.
Shi P; Zhang J; Li X; Li W; Li H; Fu P
Cell Cycle; 2021 Jul; 20(13):1295-1307. PubMed ID: 34125645
[TBL] [Abstract][Full Text] [Related]
7. LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA.
Chen M; Zhang R; Lu L; Du J; Chen C; Ding K; Wei X; Zhang G; Huang Y; Hou J
Aging (Albany NY); 2020 Nov; 12(21):22291-22312. PubMed ID: 33188158
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA SNHG6 enhances cell proliferation, migration and invasion by regulating miR-26a-5p/MAPK6 in breast cancer.
Lv P; Qiu X; Gu Y; Yang X; Xu X; Yang Y
Biomed Pharmacother; 2019 Feb; 110():294-301. PubMed ID: 30522015
[TBL] [Abstract][Full Text] [Related]
9. LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer.
Zhao W; Geng D; Li S; Chen Z; Sun M
Cancer Med; 2018 Mar; 7(3):842-855. PubMed ID: 29473328
[TBL] [Abstract][Full Text] [Related]
10. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway.
Qiao K; Ning S; Wan L; Wu H; Wang Q; Zhang X; Xu S; Pang D
J Exp Clin Cancer Res; 2019 Oct; 38(1):418. PubMed ID: 31623640
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA VCAN-AS1 promotes the malignant behaviors of breast cancer by regulating the miR-106a-5p-mediated STAT3/HIF-1α pathway.
Du P; Luo K; Li G; Zhu J; Xiao Q; Li Y; Zhang X
Bioengineered; 2021 Dec; 12(1):5028-5044. PubMed ID: 34365889
[TBL] [Abstract][Full Text] [Related]
12. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
Liu Y; Cheng T; Du Y; Hu X; Xia W
BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA CASC7 is associated with the pathogenesis of heart failure via modulating the expression of miR-30c.
Xu YL; Liu Y; Cai RP; He SR; Dai RX; Yang XH; Kong BH; Qin ZB; Su Q
J Cell Mol Med; 2020 Oct; 24(19):11500-11511. PubMed ID: 32860492
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA AC073284.4 suppresses epithelial-mesenchymal transition by sponging miR-18b-5p in paclitaxel-resistant breast cancer cells.
Wang YY; Yan L; Yang S; Xu HN; Chen TT; Dong ZY; Chen SL; Wang WR; Yang QL; Chen CJ
J Cell Physiol; 2019 Dec; 234(12):23202-23215. PubMed ID: 31215650
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA NONHSAT101069 promotes epirubicin resistance, migration, and invasion of breast cancer cells through NONHSAT101069/miR-129-5p/Twist1 axis.
Yao N; Fu Y; Chen L; Liu Z; He J; Zhu Y; Xia T; Wang S
Oncogene; 2019 Nov; 38(47):7216-7233. PubMed ID: 31444414
[TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA
Yao L; Chen L; Zhou H; Duan F; Wang L; Zhang Y
Cancer Biother Radiopharm; 2022 Oct; 37(8):636-649. PubMed ID: 32833504
[No Abstract] [Full Text] [Related]
17. Long non-coding RNA CASC7 inhibits the proliferation and migration of colon cancer cells via inhibiting microRNA-21.
Zhang Z; Fu C; Xu Q; Wei X
Biomed Pharmacother; 2017 Nov; 95():1644-1653. PubMed ID: 28954383
[TBL] [Abstract][Full Text] [Related]
18. Linc-ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR-194-3p targeting MECP2.
Zhou Q; Guo J; Huang W; Yu X; Xu C; Long X
Mol Oncol; 2020 Sep; 14(9):2231-2250. PubMed ID: 32335998
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA LINC00968 reduces cell proliferation and migration and angiogenesis in breast cancer through up-regulation of PROX1 by reducing hsa-miR-423-5p.
Sun X; Huang T; Zhang C; Zhang S; Wang Y; Zhang Q; Liu Z
Cell Cycle; 2019 Aug; 18(16):1908-1924. PubMed ID: 31213129
[No Abstract] [Full Text] [Related]
20. Long non-coding RNA CASC2 inhibits breast cancer cell growth and metastasis through the regulation of the miR-96-5p/SYVN1 pathway.
Gao Z; Wang H; Li H; Li M; Wang J; Zhang W; Liang X; Su D; Tang J
Int J Oncol; 2018 Nov; 53(5):2081-2090. PubMed ID: 30106139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
